Printer Friendly
The Free Library
21,607,437 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Rodman & Renshaw, LLC Announces Investment Opinion: Rodman & Renshaw, LLC Initiates Coverage of Palatin Technologies With A Market Outperform Rating; Analyst Sets 12 Month Target Price of $5.

NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 -- Rodman & Renshaw, LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
 initiated research coverage of Palatin Technologies (AMEX AMEX

See: American Stock Exchange
: PTN PTN - Physical Transport Network ) with a Market Outperform market outperform

An analyst recommendation that a stock is expected to outperform the overall market.
 Rating and a 12-month price target $5. Ilya Kravets, Senior Specialty Pharmaceuticals Analyst, issued the report.

About Rodman & Renshaw, LLC

Rodman & Renshaw is a privately held, full-service investment bank committed to fostering the long-term success of growth companies through capital raising, strategic advice, insightful research, and the development of institutional support. More information is available at www.rodmanandrenshaw.com

None of the research analysts or the research analyst's household has a financial interest in the securities of Palatin Technologies (including, without limitation, any option, right, warrant, future, long or short position).

As of August 31, 2005, neither Rodman & Renshaw, LLC nor its affiliates beneficially own 1% or more of any class of common equity securities of Palatin Technologies.

Neither the research analyst nor Rodman & Renshaw, LLC has any material conflict of interest with Palatin Technologies, of which the research analyst knows or has reason to know at the time of publication of this research report.

Rodman & Renshaw, LLC or its affiliates did not receive compensation from Palatin Technologies for investment banking services within the last twelve months and Rodman & Renshaw, LLC intends to seek compensation from Palatin Technologies for investment banking services within three months, following publication of the research report.

Neither the research analyst nor any member of the research analyst's household nor Rodman & Renshaw, LLC serves as an officer, director or advisory board member of Palatin Technologies.

Rodman & Renshaw, LLC does not make a market in Palatin Technologies' securities as of the date of this research report.

The above information is not intended to be used as a primary basis of investment decisions. It is not a representation by Rodman & Renshaw, LLC or an offer or the solicitation solicitation

In criminal law, the act of asking, inducing, or directing someone to commit a crime. The person soliciting another becomes an accomplice to the crime. The term also refers to the act of obtaining bribes, as well as to the crime of a prostitute who offers sexual
 of an offer to buy any security. Before investing in Palatin Technologies, you should carefully consider your risk tolerance Risk Tolerance

The degree of uncertainty that an investor can handle in regards to a negative change in the value of their portfolio.

Notes:
An investor's risk tolerance varies according to age, income requirements, financial goals, etc.
 and financial objectives.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Oct 6, 2005
Words:319
Previous Article:PerkinElmer Accelerates Strategic Focus Toward Health Sciences and Photonics; Signs Agreement to Sell Aerospace Business to Eaton Corporation; In...
Next Article:Vault Brings its ''Insider'' Approach to Media and Entertainment Industry Employers.
Topics:



Related Articles
Palatin Technologies, Inc. to Participate in Rodman & Renshaw Techvest Healthcare Conference.
Palatin Technologies, Inc. to Present at Rodman & Renshaw TechVest Global Healthcare Conference.
Rodman & Renshaw, LLC Announces Investment Opinion on Halozyme Therapeutics, Inc.
Rodman & Renshaw, LLC Announces Investment Opinion on Javelin Pharmaceuticals, Inc.
Rodman & Renshaw, LLC Announces Investment Opinion on Cephalon, Inc.
Rodman & Renshaw, LLC Announces Investment Opinion on Myriad Genetics, Inc.
Targeted Genetics to Present at the Rodman & Renshaw TechVest 7th Annual Healthcare Conference.
Rodman & Renshaw, LLC Announces Investment Opinion on Pharmacyclics.
Rodman & Renshaw, LLC Announces Investment Opinion: Rodman & Renshaw, LLC Initiates Coverage of Biomira, Inc. With A Market Outperform Rating.
Titan Pharmaceuticals to Raise $11 Million in Registered Direct Offering of Common Stock.

Terms of use | Copyright © 2013 Farlex, Inc. | Feedback | For webmasters | Submit articles